Physician profile
Loretta Smithson
NPI 1548927619
$1,635.03
in general payments reported to CMS, 2019-2025
14 companies · $902 in 2025
The $902 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $17.83 · 2023: $293 · 2024: $422 · 2025: $902.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,617.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $475.75 | 2023-2025 | |
| Medtronic, INC. | $193.92 | 2024 | Interstim, Endo Gia Ultra |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $155.70 | 2025 | Caplyta |
| Eagle Pharmaceuticals, INC. | $137.19 | 2023 | |
| Sanofi-Aventis U.S. LLC | $125.02 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $102.92 | 2025 | |
| Alkermes, INC. | $96.93 | 2025 | Lybalvi |
| Novo Nordisk INC | $87.14 | 2025 | Wegovy |
| Phathom Pharmaceuticals, INC. | $78.30 | 2024 | Voquezna |
| Exact Sciences Corporation | $62.04 | 2023-2025 | Cologuard Collection Kit |
| Coloplast Corp | $45.00 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.93 | 2023 | Jardiance |
| Axsome Therapeutics, INC. | $18.36 | 2025 | Auvelity |
| Blueprint Medicines Corporation | $17.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loretta Smithson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.